The company produces technologies to address regenerative, curative and preventable conditions and diseases with several patent-pending applications. The company developed the cGTP cellular processing facility in New York City designed to be fully integrated into an ambulatory surgery center.
More Articles on Surgery Centers:
6 Reasons ASC Joint Ventures Fail
5 Key Technology Considerations for ASCs
How ASCs Should Prepare for ACOs
IntelliCell BioSciences Has Cellular Laboratory Inspected
IntelliCell BioSciences announced its flagship cellular laboratory has been inspected by the Food and Drug Administration.
Shared risk, shared data: What leaders say is really driving payer-provider alignment
Recommended Whitepaper